Expert Persona Adopted: Senior Analyst, Biotechnology Venture Capital and R&D Strategy.
Target Review Group: Biotech Venture Capital Analysts (Focusing on career trajectory, scientific specialization, and commercialization history).
Abstract:
Jacob Eli Gunn Glanville is a computational immunoengineer and business executive known for co-founding Distributed Bio in 2012, serving as its CEO until its 2020 acquisition, and subsequently launching Centivax as its spin-out successor. Glanville’s academic background includes undergraduate work in genetics and genomics at UC Berkeley and a 2017 Ph.D. in Computational and Systems Immunology from Stanford University, specializing in adaptive receptor repertoires. Prior to his entrepreneurial endeavors, he served as a Principal Scientist at Pfizer, departing in 2012. His profile was elevated by his inclusion in the documentary series Pandemic: How to Prevent an Outbreak, and he gained media attention in 2020 for developing potential treatments to neutralize the coronavirus.
Computational Immunoengineer Jacob Glanville: Career and Scientific Milestones
2006 (Academic Foundation): Graduated from the University of California, Berkeley, where he focused on Genetics, Genomics, and Development within the Molecular and Cellular Biology program. His research involved the Glenys Thomsom HLA population genetics laboratory and the Kimmen Sjolander Berkeley Phylogenomics group.
2008–2012 (Pharmaceutical R&D): Joined Pfizer, achieving the rank of Principal Scientist before his departure.
2012 (Entrepreneurial Founding): Co-founded the startup company Distributed Bio, serving as its Chief Executive Officer.
2012–2017 (Doctoral Research): Concurrently pursued a Ph.D. in Computational and Systems Immunology at Stanford University. His doctoral advisors were Scott D. Boyd and Mark M. Davis.
2017 (Dissertation Focus): Completed his doctorate with a dissertation titled Reading the adaptive receptor repertoires.
2020 (Corporate Transaction): Distributed Bio was acquired.
2020 (Spin-out Launch): Founded Centivax, which was spun out from the acquired Distributed Bio. He currently serves as its Chief Executive Officer.
Key Scientific Collaborators: Microbiologist Sarah Ives was identified as a research Principal Scientist at Distributed Bio who worked with Glanville on the influenza project featured in the Netflix documentary Pandemic: How to Prevent an Outbreak.
Public Profile: Glanville has been featured in the documentary series Pandemic: How to Prevent an Outbreak and was noted in March 2020 for efforts to develop a treatment for COVID-19.
Error: value error Invalid operation: The response.text quick accessor requires the response to contain a valid Part, but none were returned. The candidate's finish_reason is 1.